News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,842 Results
Type
Article (54919)
Company Profile (338)
Press Release (706585)
Multimedia
Podcasts (102)
Webinars (13)
Section
Business (218929)
Career Advice (2896)
Deals (37944)
Drug Delivery (123)
Drug Development (87147)
Employer Resources (186)
FDA (17316)
Job Trends (16202)
News (372457)
Policy (36361)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (5)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2915)
Academic (1)
Accelerated approval (5)
Adcomms (29)
Allergies (91)
Alliances (53795)
ALS (98)
Alzheimer's disease (1475)
Antibody-drug conjugate (ADC) (149)
Approvals (17285)
Artificial intelligence (283)
Autoimmune disease (27)
Automation (16)
Bankruptcy (391)
Best Places to Work (12239)
BIOSECURE Act (21)
Biosimilars (118)
Biotechnology (218)
Bladder cancer (70)
Brain cancer (29)
Breast cancer (290)
Cancer (2292)
Cardiovascular disease (197)
Career advice (2428)
Career pathing (34)
CAR-T (162)
Cell therapy (447)
Cervical cancer (20)
Clinical research (70566)
Collaboration (877)
Compensation (535)
Complete response letters (29)
COVID-19 (2808)
CRISPR (45)
C-suite (252)
Cystic fibrosis (104)
Data (2144)
Decentralized trials (2)
Denatured (30)
Depression (51)
Diabetes (285)
Diagnostics (6726)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (130)
Drug pricing (123)
Drug shortages (32)
Duchenne muscular dystrophy (99)
Earnings (89739)
Editorial (43)
Employer branding (23)
Employer resources (159)
Events (120611)
Executive appointments (751)
FDA (18578)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (783)
Gene editing (113)
Generative AI (25)
Gene therapy (327)
GLP-1 (830)
Government (4919)
Grass and pollen (6)
Guidances (52)
Healthcare (20167)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (140)
Indications (29)
Infectious disease (2966)
Inflammatory bowel disease (148)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (95)
Interviews (558)
IPO (17194)
IRA (49)
Job creations (4401)
Job search strategy (2008)
Kidney cancer (11)
Labor market (38)
Layoffs (529)
Leadership (22)
Legal (9059)
Liver cancer (78)
Lung cancer (333)
Lymphoma (150)
Machine learning (6)
Management (63)
Manufacturing (326)
MASH (73)
Medical device (14047)
Medtech (14052)
Mergers & acquisitions (21272)
Metabolic disorders (759)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (106)
Neuropsychiatric disorders (33)
Neuroscience (2051)
NextGen: Class of 2025 (7186)
Non-profit (4894)
Northern California (2638)
Now hiring (39)
Obesity (413)
Opinion (263)
Ovarian cancer (75)
Pain (93)
Pancreatic cancer (84)
Parkinson's disease (157)
Partnered (21)
Patents (240)
Patient recruitment (108)
Peanut (51)
People (62657)
Pharmaceutical (100)
Pharmacy benefit managers (21)
Phase I (21899)
Phase II (30898)
Phase III (23185)
Pipeline (1181)
Policy (164)
Postmarket research (2989)
Preclinical (9341)
Press Release (71)
Prostate cancer (104)
Psychedelics (38)
Radiopharmaceuticals (258)
Rare diseases (416)
Real estate (6645)
Recruiting (72)
Regulatory (24619)
Reports (47)
Research institute (2579)
Resumes & cover letters (456)
Rett syndrome (4)
RNA editing (4)
RSV (49)
Schizophrenia (77)
Series A (136)
Series B (88)
Service/supplier (16)
Sickle cell disease (58)
Southern California (2268)
Special edition (17)
Spinal muscular atrophy (160)
Sponsored (32)
Startups (3948)
State (2)
Stomach cancer (16)
Supply chain (74)
Tariffs (38)
The Weekly (70)
United States (23238)
Vaccines (768)
Venture capitalists (42)
Weight loss (293)
Women's health (36)
Worklife (18)
Date
Today (108)
Last 7 days (644)
Last 30 days (2581)
Last 365 days (34373)
2025 (10365)
2024 (36942)
2023 (41842)
2022 (53089)
2021 (57789)
2020 (56649)
2019 (49960)
2018 (37848)
2017 (34948)
2016 (34973)
2015 (40948)
2014 (35077)
2013 (30467)
2012 (32478)
2011 (33060)
2010 (31280)
Location
Africa (959)
Alabama (53)
Alaska (7)
Arizona (245)
Arkansas (14)
Asia (44486)
Australia (7795)
California (6057)
Canada (1996)
China (534)
Colorado (268)
Connecticut (273)
Delaware (146)
Europe (97308)
Florida (904)
Georgia (207)
Idaho (61)
Illinois (566)
India (28)
Indiana (322)
Iowa (10)
Japan (164)
Kansas (104)
Kentucky (25)
Louisiana (10)
Maine (62)
Maryland (914)
Massachusetts (4577)
Michigan (222)
Minnesota (402)
Mississippi (2)
Missouri (88)
Montana (29)
Nebraska (25)
Nevada (61)
New Hampshire (66)
New Jersey (1725)
New Mexico (31)
New York (1725)
North Carolina (1040)
North Dakota (7)
Northern California (2638)
Ohio (203)
Oklahoma (14)
Oregon (41)
Pennsylvania (1358)
Puerto Rico (12)
Rhode Island (34)
South America (1345)
South Carolina (22)
South Dakota (1)
Southern California (2268)
Tennessee (104)
Texas (904)
Utah (184)
Virginia (154)
Washington D.C. (66)
Washington State (571)
West Virginia (3)
Wisconsin (54)
761,842 Results for "aurinia formerly known as isotechnika pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Aurinia Pharmaceuticals Shareholder Urges Fellow Shareholders to Withhold Support for CEO Peter Greenleaf
Lucien Selce, who owns approximately 2.2% of the outstanding shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”), today issued the following letter to Aurinia shareholders.
June 3, 2024
·
4 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
BioCapital
Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024
Aurinia Pharmaceuticals Inc., announced an oral presentation at the European Alliance of Associations for Rheumatology 2024 taking place in Vienna, Austria June 12-15.
June 5, 2024
·
7 min read
Press Releases
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
February 27, 2025
·
9 min read
BioCapital
Aurinia Announces 2024 Annual General Meeting Results
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced voting results for its 2024 annual general meeting (the Meeting) of shareholders held on June 14, 2024.
June 14, 2024
·
2 min read
Press Releases
Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
February 21, 2025
·
1 min read
Business
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Aurinia Pharmaceuticals Inc. issued its financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
22 min read
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
BioCapital
Aurinia Provides Update on Proxy Statement
Aurinia Pharmaceuticals Inc. filed a supplement to the Company’s Management Information and Proxy Statement dated June 3, 2024 for its Annual General Meeting of Shareholders to be held on June 14, 2024.
June 3, 2024
·
1 min read
1 of 76,185
Next
